LifeStance Health (LFST) Liabilities and Shareholders Equity (2020 - 2026)

LifeStance Health (LFST) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $2.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 1.96% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $8.6 billion (up 2.31% YoY), while the FY2025 annual figure was $2.2 billion, up 4.04% from the prior year.
• Liabilities and Shareholders Equity declined to $2.1 billion in Q1 2026 per LFST's latest filing, from $2.2 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.2 billion in Q4 2025 and bottomed at $2.0 billion in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $2.1 billion across 5 years, with a median of $2.1 billion in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity gained 12.8% — and 2024, when it declined 3.09%.
• LifeStance Health's Liabilities and Shareholders Equity stood at $2.2 billion in 2022, then declined by 2.94% to $2.1 billion in 2023, then climbed by 0.39% to $2.1 billion in 2024, then rose by 4.04% to $2.2 billion in 2025, then dropped by 2.63% to $2.1 billion in 2026.
• Business Quant data shows LFST's Liabilities and Shareholders Equity at $2.1 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.1 billion in Q3 2025.